GeneLink Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Sales/Revenue
6,377.40
8,561.50
7,840.00
4,684.60
2,136.10
Cost of Goods Sold (COGS) incl. D&A
1,899.50
3,780.40
3,021.70
1,869.60
1,846.50
Gross Income
4,477.90
4,781.10
4,818.30
2,815.00
289.70
SG&A Expense
6,798.40
7,368.90
7,221.00
6,381.60
3,693.20
EBIT
2,320.50
2,587.80
-
3,566.60
3,403.50
Unusual Expense
-
-
-
-
12.20
Non Operating Income/Expense
3.00
-
-
-
669.10
Interest Expense
286.10
128.90
233.60
265.80
331.10
Pretax Income
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
Consolidated Net Income
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
Net Income
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
Net Income After Extraordinaries
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
Net Income Available to Common
2,603.50
2,716.80
2,634.70
3,830.20
3,051.70
EPS (Basic)
0.03
0.03
0.02
0.02
0.01
Basic Shares Outstanding
82,531.00
111,837.70
134,804.70
180,567.50
214,447.00
EPS (Diluted)
0.03
0.02
0.02
0.02
0.01
Diluted Shares Outstanding
82,531.00
111,837.70
134,804.70
180,567.50
214,447.00
EBITDA
2,233.40
2,462.20
2,242.30
3,431.80
3,190.50
Non-Operating Interest Income
-
-
1.60
2.20
1.50

About GeneLink

View Profile
Address
8250 Exchange Drive
Orlando Florida 32809
United States
Employees -
Website http://www.genelinkbio.com
Updated 07/08/2019
GeneLink, Inc. engages in the development of genetics-based assessment products for pharmaceutical applications and DNA storage purpose. It also offers genetically-based nutritional supplements. The company was founded by Robert P.